Skip to main content
logo
Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
84.02
-4.01 (-4.56%)
At close: Mar 12, 2026, 4:00 PM EDT
85.27
+1.25 (1.49%)
After-hours: Mar 12, 2026, 7:39 PM EDT

Guardant Health Revenue by Segment

Period EndingDec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
Precision Oncology Testing
----687.94M645.54M598.36M557.09M514.25M485.86M454.49M421.31M
Precision Oncology Testing Growth
----33.77%32.87%31.66%32.23%31.17%32.40%32.05%29.74%
Oncology
683.60M------------------------
Biopharma and Data
210.13M------------------------
Screening
79.73M------------------------
Development Services
----51.08M46.72M45.45M46.64M49.70M49.93M55.67M60.85M
Development Services Growth
----2.78%-6.43%-18.36%-23.35%-13.55%-21.74%-12.95%-8.32%
Licensing and Other
8.56M------------------------

Revenue by Geography

Period EndingDec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
Unitied States
923.28M851.33M781.99M733.42M697.16M648.18M603.81M564.96M
Unitied States Growth
32.43%31.34%29.51%29.82%32.41%29.19%26.56%25.92%
International
58.74M51.51M47.13M40.84M42.12M44.07M40.00M38.76M
International Growth
39.45%16.88%17.83%5.36%12.56%29.39%20.93%15.73%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.